by Admin | Apr 12, 2022 | Portfolio News
First regulatory milestone as part of a strategy to advance patient care April 11, 2022 08:00 AM Eastern Daylight Time CAMPBELL, Calif.–(BUSINESS WIRE)–Truvic Medical, Inc., a wholly owned subsidiary of Imperative Care, Inc., today announced that...
by Admin | Feb 16, 2022 | Delos News
HONG KONG, Feb. 15, 2022 /PRNewswire/ — Delos Capital, a Hong Kong-headquartered life sciences venture capital fund with a global presence and investment mandate, announces the successful $300 million first close of its Fund III....
by Admin | Jan 14, 2022 | Portfolio News
Allecra receives upfront, development and commercial milestone payments, in addition to double-digit royaltiesADVANZ gains commercial rights for cefepime/enmetazobactam in the European Union, the United Kingdom, Switzerland, and NorwayCefepime/enmetazobactam has...
by Admin | Dec 16, 2021 | Portfolio News
MENDHAM, N.J. and WARMINSTER, Pa., December 14, 2021 – Antios Therapeutics, Inc. (“Antios”) and Arbutus Biopharma Corporation (Nasdaq: ABUS) today announced that the first patient has been dosed in a triple combination treatment in patients with chronic hepatitis...
by Admin | Dec 9, 2021 | Portfolio News
Platform combines the innate immuno-stimulatory effect of the myxoma virus with anti-tumor immune stimulation that uniquely target multiple aspects of cancer immunity to treat solid tumors and hematological cancersOncoMyx is developing a next generation oncolytic...
